Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Cirrhosis 1 Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 30 Capecitabine 26 Fluorouracil 20 Irinotecan 19 tislelizumab 18 apatinib 16 Paclitaxel 13 Cisplatin 13 S 1 (combination) 12 Radiotherapy 12 Leucovorin 11 Bevacizumab 11 Laparoscopy 9 Drug Therapy 9 Cetuximab 9 sintilimab 8 Endoscopic Mucosal Resection 8 Radiation 7 Gemcitabine 7 Docetaxel 7 camrelizumab 6 XELOX 6 Surgical Procedures, Operative 6 Propranolol 6 Nivolumab 6 Neoadjuvant Therapy 6 Immune Checkpoint Inhibitors 6 Folfox protocol 6 Levoleucovorin 5 HMPL-013 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Nadolol × Gastrointestinal × Clear all

NCT00567216 2010-06-08

GVO-nadolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡